Livalo Acute Myocardial Infarction Study (LAMIS)

Completed

• Conditions: Acute Myocardial Infarction

• Registration Number: NCT01265706
• Lead Sponsor: JW Pharmaceutical

Brief Summary

This study is performed to observe the incidence of major cardiovascular events in Korean patients with AMI after giving pitavastatin 2mg and 4mg longer than 1 year.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2010-10-18
• Study First Submitted QC: 2010-12-22
• Study First Posted: 2010-12-23
• Primary Completion: 2014-05
• Status Verified: 2014-12
• Study Completion: 2014-12
• Last Update Submitted: 2014-12-12
• Last Update Posted: 2014-12-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients with STEMI, NSTEMI

• Patients satisfying at least one of the followings

  1. Patients with LDL-C ≥ 130 mg/dL
  2. Patients with LDL-C ≥ 100 mg/dL who are regarded as required cholesterol lowering therapy by the investigator
  3. Patients taking statin are required continuous cholesterol lowering therapy

• Patients satisfying at least two of the followings

  1. The change of Ischemic ECG
  2. CK, CK-MB, Troponin-I increased more than two times
  3. The symptom of ACS

Exclusion Criteria

1. Patients with in-stent restenosis after PCI or coronary artery bypass
2. Patients with cardiogenic shock
3. Patients with severe heart failure (Left ventricular ejection fraction is less than 30%)
4. Patients who are taking cyclosporine
5. Patients who experienced hypersensitivity to pitavastatin
6. Patients under dialysis treatment
7. Patients who are participating other clinical trials
8. Patients who can not stop taking concomitant drugs
9. Pregnant or lactating women or suspected pregnancy
10. Patients who are regarded as ineligible for this study by the investigator

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of TLR-MACE for 1 year after enrollment	1 year after enrollment

Secondary Outcome Measures

Name	Time	Method
Incidence of TVR-MACE for 1 year after enrollment	1 year after enrollment

Trial Locations

Locations (1)

Chonnam National University Hospital; 🇰🇷 Gwangju, Korea, Republic of